Koyfin Home > Directory > Health Care > Acorda Therapeutics > Preferred Equity

Acorda Therapeutics Preferred Equity Chart (ACOR)

Acorda Therapeutics annual/quarterly Preferred Equity from 2020 to 2020.
Other Balance Sheet Metrics:
  • Acorda Therapeutics Total Assets for the quarter ending December 12, 2018 was $1,300m a 8.66% increase of 113m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Equity for the quarter ending December 12, 2018 was $612m a 10.14% increase of 62m year over year
View Chart On Koyfin